Hot Papers

In the April 1 issue,1 I discussed new gratis features that are now accessible from the Institute for Scientific Information: highly cited authors at www.isihighlycited.com and the editorial sections of Essential Science Indicators at www.in-cites.com, www.esi-topics.com, and www.sciencewatch.com. As I wrote then, I founded ISI in 1954, but I am no longer a shareholder, although I retain an office and the title of chairman emeritus. Essential Science Indicators and its editorial features such as

Written byEugene Garfield
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Essential Science Indicators and its editorial features such as Fast-Breaking Papers (in www.esi-topics.com) represent an expansion of similar past endeavors well known to long-time readers of Current Contents or The Scientist. My essays, containing descriptions of these efforts, appeared regularly in Current Contents. These essays and all my other publications over a 45-year period can be accessed free at www.eugenegarfield.org.

It was not obvious in the early days of ISI that the Science Citation Index could be used to identify significant "current" research. Due to time lags in publication and citation, it was generally assumed that this was not possible because of a seemingly inherent lack of currency in citation data. Among science journals, the average cited reference is about six years old and somewhat less for life science journals.

What was overlooked, however, was the fact that, even just after World War II, citation of significant breakthroughs usually was ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies